Prospective noninterventional study on the use of panitumumab monotherapy in patients with recurrent or progressive colorectal cancer: the VECTIS study

PURPOSE: Epidermal growth factor receptor-targeted monoclonal antibodies are active as monotherapy beyond second-line treatment. Skin toxicities (STs) are common during treatment, and a positive association between ST severity and patient outcome has been reported. This study collected information o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lakomy, Radek, Rogowski, Wojciech, Piko, Bela, Mihaylova, Zh, Pritzova, Eva, Kvocekova, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627397/
https://www.ncbi.nlm.nih.gov/pubmed/26566372
http://dx.doi.org/10.2147/CMAR.S86796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627397/
https://www.ncbi.nlm.nih.gov/pubmed/26566372
http://dx.doi.org/10.2147/CMAR.S86796

Ejemplares similares